跳至主要内容
临床试验/ACTRN12613000809730
ACTRN12613000809730尚未招募未知

In medically-complex children aged 4-36 months in the acute inpatient setting, does group speech-language therapy compared to individual speech-language therapy improve language development outcomes - a controlled trial.

Queensland Health.0 个研究点目标入组 34 人开始时间: 2013年7月23日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
4 Months 至 36 Months(—)
性别
All

入选标准

  • Inclusion Criteria: Group Speech-Language Therapy [n=17] -Children in the General Medical Ward; aged 4-36 months; no diagnosed global developmental delay. Individual Speech-Language Therapy [n=17] - Children in the Surgical and Infectious Diseases Wards aged 4-36 months; no diagnosed global developmental delay. Due to bed configuration and the risk of infection from children on alternative wards it is not appropriate to individually allocate children to treatments groups via randomisation. Children who can mix freely on general medical wards will be assigned to group intervention.

排除标准

  • Children admitted for a short stay (e.g. less than 5 months, shorter than the treatment period); patients for whom English is not their primary language (e.g. assessments are only validated for children for whom English is their primary language). Children with global developmental delay, or acquired brain injury, neurological impairment, hearing impairment, visual impairment, seizures, genetic syndrome with associated cognitive impairment.

研究者

发起方
Queensland Health.

相似试验